Postmenopozal Stronsiyum Ranelat Tedavisinden Sonra Sıçan Kalp Dokusundaki Paraoksonaz ve Aril Esteraz Aktivitesindeki Değişiklikler
Türkçe Özet:Amaç: Bu çalışmada deneysel osteoporoz modeli oluşturulan sıçanlarda, kemik formasyonunu arttıran post-menopozal bir ilaç olan stronsiyum ranelatın kalp dokusundaki paraoksonaz ve aril esteraz enzim aktiviteleri üzerindeki etkileri incelenmiştir. Yöntem: Çalışmada 28 adet dişi Wistar albino sıçan kullanılmış ve her bir grupta 7 hayvan olacak şekilde 4 gruba ayrılmıştır. Bu gruplar kontrol grubu (grup 1), stronsiyum ranelat grubu (grup 2), overektomi grubu (grup 3) ve overektomi uygulandıktan 3 ay sonra 3 ay boyunca stronsiyum ranelat uygulanan grup (grup 4) olmak üzere tasarlanmıştır. Tüm gruplardaki hayvanların kalp dokuları izole edilmiş ve paraoksonaz ve aril esteraz enzim aktivitelerine bakılmıştır. İstatistiksel analiz için SPSS 16.0 ve ANOVA testi kullanılmıştır. Bulgular: Yapılan çalışmada gerek paraoksonaz gerekse aril esteraz enzim aktivitelerinin grup 2, grup 3 ve grup 4\'te kontrol grubuna kıyasla düşük olduğu tespit edildi (p<0.05). Sonuç: Bulunan sonuçlar post-menopozal dönemin ve stronsiyum ranelat kullanımının kalp paraoksonaz ve aril esteraz enzim aktivitelerini azalttığını ve organizmayı kalp damar hastalıklarına duyarlı hale getirebileceğini göstermektedir.
Anahtar Kelimeler:
Paraoksonaz, aril esteraz, stronsiyum ranelat, osteoporoz, ateroskleroz
Postmenopozal Stronsiyum Ranelat Tedavisinden Sonra Sıçan Kalp Dokusundaki Paraoksonaz ve Aril Esteraz Aktivitesindeki Değişiklikler
AbstractAlterations on Paraoxonase and Aryl Esterase Activities in the Rat Heart Tissue After Postmenopausal Strontium Ranelate Therapy Objective: In this study, the effect of strontium ranelate which is used in treatment of postmenopausal syndromes enhancing the bone formation on paraoxonase and aryl esterase activities was investigated in the rats with osteoporosis. Method: 28 female Wistar albino rats were used to establish experimental osteoporosis model. Experimental animals were divided into 4 groups. Each group was composed of 7 rats. The group 1 was defined as “control group”. Group 2 was the one received strontium ranelate. Group 3 underwent ovariectomy operation and did not receive any drug. Group 4 was treated with strontium ranelate for three months after three months from the ovariectomy operation. Heart tissues of the animals in each group were isolated. Paraoxonase and aryl esterase activities were investigated. The data were statistically analyzed by utilizing SPSS 16.0 and ANOVA Test. Results: In this study, paraoxonase and aryl esterase activities in groups 2, 3 and 4 were found to be lower in comparison to that of the control group (p<0.05). Conclusion: The obtained data indicate that paraoxonase and aryl esterase levels in heart tissues get reduced during the postmenopausal period upon administration of strontium ranelate. In turn, this could make the organism sensitive to the cardiovascular diseases.
Keywords:
Paraoxonase, aryl esterase, strontium ranelate, osteoporosis, atherosclerosis,
___
- Tung S, Iqbal J. Evolution, aging, and osteoporosis. Ann N Y Acad Sci 2007;11162499—506.
- Zhao H, Patrick Ross F. Mechanisms of osteoclastic secretion. Ann N Y Acad Sci 2007;11161238-44.
- Crepaldi G, Romanato G, Tonin P, Maggi S. Osteoporosis and body composition. J Endocrinol Invest 2007;30:42—7.
- Cashman KD. Diet, nutrition, and bone health. J Nutr 2007;137:2507—12.
- Lindsay R. Prevention and treatment of osteoporosis. Lancet 1993;341:801-5.
- Blahos J. Treatment and prevention of osteoporosis. Wien Med Wochenschr 2007;157:589—92.
- Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr Rheumatol Rep 2008;10:92-6.
- Nevitt MC. Epidemiology of osteoporosis. Rheum Dis Clin North Am 1994;20:535-59.
- Sutherland WH, Manning PJ, de Jong SA, Allum AR, Jones SD, Williams SM. Hormone—replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women. Metabolism 2001;50:319—24.
- Topçuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, Topçuoglu D. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. Tohoku J Exp Med 2005;205:79—86.
- Gupta G, Aronow WS. Treatment of postmenopausal osteoporosis. Compr Ther 2007;33:114-9.
- Brochier ML, Arwidson P. Coronary heart disease risk factors in women. Eur Heart J 1998;19:45-52.
- Toumis S. Improvement in bone strength parameters. The
- role of strontium ranelate. J Mnsenloskelet Neuronal
- Reginster JY, Sarlet N, Lejeune E, Leonori L. Strontium
- ranelate: a new treatment for postmenopausal osteoporosis
- Akçay YD, Sagin FG, Sendağ F, Oztekin K, Sozmen EY.
- Effects of estrogen-only therapy on LDL oxidation in
- Zago V, Sanguinetti S, Brites F, Berg G, Verona J, Basilio
- F, Wikinski R, Schreier L. Impaired high density
- Kwok S, Selby PL, McElduff P, Laing l, Mackness B,
- Mackness Ml, Prais H, Morgan J, Yates AP, Durrington
- Fenkci IV, Serteser M, Fenkci S, Akyol AM. Effects of
- intranasal estradiol treatment on serum paraoxonase and
- Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo—
- Parmo SL, La Du BN. Paraoxonase inhibits high-density
- Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation
- of paraoxonase (PON1) activity. Biochem Pharmacol
- Eckerson HW, Wyte CM, La Du BN. The human serum
- paraoxonase/arylesterase polymorphism. Am J Hum Genet
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein
- measurement with the Folin phenol reagent. J Biol Chem
- Kumru S, Aydin S, Aras A, Gursu MF, Gulcu F. Effects of
- surgical menopause and estrogen replacement therapy on
- Ercal N, Gurer—Orhan H, Aykin—Burns N. Toxic metals and
- oxidative stress part I: mechanisms involved in metal— induced oxidative damage. Curr Top Med Chem 2001;1z529—39.
- Verit FF, Celik H, Yazgan P, Erel O, Geyikli I. Paraoxonase—
- Bin Ali A, Zhang Q, Lim YK, Fang D, Retnam L, Lim SK.
- Expression of major HDL-associated antioxidant PON-l is gender dependent and regulated during inşammation. Free Radie Biol Med 2003;34:824—9.
- Oh HY, Kim SS, Chung HY, Yoon S. Isoşavone
- supplements exert hormonal and antioxidant effects in postmenopausal Korean women with diabetic retinopathy. J Med Food 2005;8:1—7.
- Yayın Aralığı: Yılda 3 Sayı
- Başlangıç: 2008
- Yayıncı: Mersin Üniversitesi Sağlık Bilimleri Enstitüsü
Sayıdaki Diğer Makaleler
Stres ve Demansta Hipotalamus-Hipofiz-Adrenal Ekseninin Rolü
Mehmet BERKÖZ, Serap YALIN, Ülkü ÇÖMELEKOĞLU, Özgün SAĞIR, Pelin EROĞLU, Fatma SÖĞÜT
Nikotin ve Antagonisti Mecamylaminin Kurbağa (Rana ridibunda) İskelet Kası Üzerine Etkileri
Dilek KUMARGAL, Ülkü ÇÖMELEKOĞLU, Ali AŞKIN
Seyhan Şahan FIRAT, Necmiye CANACANKATAN, Belma KORKMAZ, Hatice YILDIRIM, Lülüfer TAMER, A Nihal SARI, Bahar TUNÇTAN